EMN's Q3 sales revenue grew 9% year-over-year due to volume growth. Adjusted EBIT margin increased by 360 basis points from last year. Investment approved for a new methanolysis facility in Longview, Texas. Returned $195 million to shareholders via buybacks and dividends. 2024 adjusted EPS guidance remains intact, expecting between $7.50-$7.70.
Strong revenue growth and EBIT margin boost indicate operational efficiency, similar to past quarters with successful cost management.
Investment in new facility may drive growth beyond 2025, as seen with previous capacity expansions.
The article directly affects financial performance and strategic growth plans significant to EMN’s future valuation.